Enzo Biochem, Inc.
ENZ was delisted on the 17th of April, 2025.
87 hedge funds and large institutions have $94.8M invested in Enzo Biochem, Inc. in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 31 increasing their positions, 32 reducing their positions, and 13 closing their positions.
7,000% more call options, than puts
Call options by funds: $142K | Put options by funds: $2K
3% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 32
5% less funds holding
Funds holding: 92 → 87 (-5)
6% less capital invested
Capital invested by funds: $101M → $94.8M (-$6.36M)
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.2M |
| 2 |
TAM
THB Asset Management
Norwalk,
Connecticut
|
+$2.84M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$788K |
| 4 |
GIP
Granite Investment Partners
El Segundo,
California
|
+$577K |
| 5 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$369K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EI
EAM Investors
Solana Beach,
California
|
-$3.53M |
| 2 |
CCM
Corsair Capital Management
New York
|
-$1.09M |
| 3 |
PRC
Platte River Capital
Denver,
Colorado
|
-$949K |
| 4 |
Millennium Management
New York
|
-$914K |
| 5 |
RFC
Russell Frank Company
Seattle,
Washington
|
-$680K |
ENZ Hedge Fund Activity: Q4 2014 in Review
87 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q4 2014, worth a combined $94.8M — down 6.3% from $101M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of ENZ and 9 opened new positions — a net loss of 4 holders — while 32 trimmed existing stakes and 31 added.
The largest buyer was Wellington Management Group, adding an estimated $10.2M. The largest seller was EAM Investors, exiting entirely with an estimated $3.53M sold.
- 87 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q4 2014, down from 92 in Q3 2014.
- Funds reported $94.8M of Enzo Biochem, Inc. stock for Q4 2014, down 6.3% quarter-over-quarter.
- 9 funds opened new Enzo Biochem, Inc. positions in Q4 2014 and 13 closed out, a net change of -4 holders.
- The largest Enzo Biochem, Inc. buyer in Q4 2014 was Wellington Management Group, an estimated $10.2M added.
- The largest Enzo Biochem, Inc. seller in Q4 2014 was EAM Investors, an estimated $3.53M sold.
Based on aggregated 13F filings for Q4 2014.